Vaxxinity Statistics Share Statistics Vaxxinity has 126.78M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 126.78M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0.21% Shares Floating 55.62M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 4.22M, so undefined% of the outstanding
shares have been sold short.
Short Interest 4.22M Short % of Shares Out n/a Short % of Float 7.59% Short Ratio (days to cover) 13.97
Valuation Ratios The PE ratio is -1.89 and the forward
PE ratio is null.
Vaxxinity's PEG ratio is
0.08.
PE Ratio -1.89 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.01 P/FCF Ratio 0 PEG Ratio 0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vaxxinity.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.89,
with a Debt / Equity ratio of 1.13.
Current Ratio 1.89 Quick Ratio 1.89 Debt / Equity 1.13 Debt / EBITDA -270.61 Debt / FCF -0.26 Interest Coverage -83.74
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-998.84 Employee Count 57 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -56.93K Effective Tax Rate 100%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.07, so Vaxxinity's
price volatility has been higher than the market average.
Beta 1.07 52-Week Price Change n/a 50-Day Moving Average 0.01 200-Day Moving Average 0.04 Relative Strength Index (RSI) 47.47 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit -2.23M Operating Income -58.28M Net Income -56.93K EBITDA -56.05K EBIT 639.07K Earnings Per Share (EPS) -0.45
Full Income Statement Balance Sheet The company has 5.04M in cash and 15.17M in
debt, giving a net cash position of -10.13M.
Cash & Cash Equivalents 5.04M Total Debt 15.17M Net Cash -10.13M Retained Earnings -361.64M Total Assets 44.31M Working Capital 15.63M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -57.24M
and capital expenditures -803K, giving a free cash flow of -58.04M.
Operating Cash Flow -57.24M Capital Expenditures -803K Free Cash Flow -58.04M FCF Per Share -458.79
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
